Commentary: drug-associated atypical femoral fractures (DaAFFs): balancing the facts. [electronic resource]
Producer: 20140929Description: 2340-2 p. digitalISSN:- 1945-7197
- Antibodies, Monoclonal, Humanized -- therapeutic use
- Bone Density Conservation Agents -- adverse effects
- Bone Neoplasms -- complications
- Denosumab
- Diphosphonates -- adverse effects
- Drug Utilization
- Femoral Fractures -- chemically induced
- Humans
- Neoplasms -- drug therapy
- Osteonecrosis -- chemically induced
- Osteoporosis, Postmenopausal -- drug therapy
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.